跳至主要内容
临床试验/NCT00894231
NCT00894231已完成4 期

Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic Rhinitis

AAADRS Clinical Research Center1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2009年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
The change in objective measure of inflammation nasal NO after LC treatment.

研究概览

简要总结

The purpose of this study is to noninvasively measure the anti-inflammatory effect of levocetirizine after two weeks of treatment in allergic rhinitis subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
12 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ICF signed
  • Diagnosis of PAR for 6-12 months greater
  • 12 years and older
  • Decreased nasal NO values at baseline
  • Compliance and ability to perform maneuvers and responsibilities

排除标准

  • Oral or systemic steroids for 60 days prior
  • Inhaled, nasal, nebulized steroids w/i 4 weeks
  • Hospitalization or life threatening asthma
  • Use of nasal or oral antihistamines w/i 4 weeks
  • Upper or lower airways infection
  • Direct cigarette smoke exposure

研究组 & 干预措施

placebo

Placebo Comparator

Sugar tablet

干预措施: placebo (Drug)

Xyzal

Active Comparator

干预措施: levocetirizine (Xyzal) (Drug)

结局指标

主要结局

The change in objective measure of inflammation nasal NO after LC treatment.

时间窗: two weeks

次要结局

  • The change in nasal eosinophils, QOL and diary scores after LC treatment.(two weeks)

研究者

发起方
AAADRS Clinical Research Center
申办方类型
Other

研究点 (1)

Loading locations...

相似试验